Skip to main content

Advertisement

SpringerLink
Log in

Bisphosphonate-related osteonecrosis of the jaw: a review of the potential efficacy of low-level laser therapy

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Osteonecrosis of the jaw (ONJ) resulting from administration of bisphosphonates (BP) or denosumab is a rare but severe complication in cancer patients. Complete remission depends on the stage of ONJ; it can be estimated in the range of 20–30 %. Low-level laser therapy (LLLT) is a logical additional option, as it has been recognized effective for the management of chemotherapy and/or radiotherapy-induced mucositis. LLLT irradiation has anti-inflammatory actions and thus can help to control pain, as well as biostimulating properties with favorable actions on bacterial control and wound healing. We review the results of seven published studies of LLLT in BP-associated ONJ. LLLT results in an overall response rate of 55 % superior to that observed in controls (30 %). Our review suggests that there might be an advantage to add LLLT to the “classical” management of ONJ. This therapy is easy to administer and is not associated with any known side effects. Further research is needed to remove any doubt of protection or enhancement of carcinogenic processes. We believe that prospective well-controlled studies of LLLT in ONJ are warranted. If the positive results are confirmed, it would represent a great improvement for the quality of life of many patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Reference

  1. Lee S-H et al. (2014) Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies. Support Care Cancer 22:553–560

    Article  PubMed  Google Scholar 

  2. Campisi G et al. (2007) Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. Ann Oncol 18(6):vi168–vi172

    PubMed  Google Scholar 

  3. Migliorati CA et al. (2011) Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review, Nature 2011. Nat Rev Endocrinol 7:34–42

    Article  CAS  PubMed  Google Scholar 

  4. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 2007; 65: 369

  5. Ruggiero SL et al. (2009) Bisphosphonate-related osteonecrosis of the Jaw: Diagnosis, prevention, and management. Annu Rev Med 60:85–96

    Article  CAS  PubMed  Google Scholar 

  6. Vescovi P et al. (2010) Bisphosphonate-related osteonecrosis of the jaw (BRONJ) therapy. A critical review. Minerva Stomatol 59(4):181–213

    CAS  PubMed  Google Scholar 

  7. Vescovi P et al. (2012) Bisphosphonate-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. J Oral Pathol Med 41:214–221

    Article  CAS  PubMed  Google Scholar 

  8. Atalay B et al. (2011) Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery? Lasers Med Sci 26(6):815–823

    Article  PubMed  Google Scholar 

  9. Romeo U et al. (2011) Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. Photomed Laser Surg 29(7):447–452

    Article  PubMed  Google Scholar 

  10. Scoletta M et al. (2010) Effect of low-level laser irradiation on bisphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study. Photomed Laser Surg 28(2):179–184

    Article  CAS  PubMed  Google Scholar 

  11. Martins MAT et al. (2012) Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study. Oral Oncol 48:79–84

    Article  PubMed  Google Scholar 

  12. Altay MA et al. (2014) Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: a retrospective analysis of 11 cases. Photomed Laser Surg 32(8):468–475

    Article  CAS  PubMed  Google Scholar 

  13. Angiero F et al. (2009) Osteonecrosis of the jaws caused by bisphosphonates: evaluation of a new therapeutic approach using the Er: YAG laser. Lasers Med Sci 24(6):849–856

    Article  PubMed  Google Scholar 

  14. Vescovi P et al. (2013) Case series of 589 tooth extractions in patients under bisphosphonates therapy, Proposal of a clinical protocol supported by Nd: YAG low-level laser therapy. Med Oral Patol Oral Cir Bucal 18(4):e680–e685

    Article  PubMed  PubMed Central  Google Scholar 

  15. Vescovi P et al. (2014) Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw. Int J Dent 2014:107690

    Article  PubMed  PubMed Central  Google Scholar 

  16. Stübinger S et al. (2007) Le laser Er: YAG dans le domaine de la chirurgie dento-alvéolaire. Rev Mens Suisse Odontostomatol 117(11):1144–1146

    Google Scholar 

  17. Gerbi ME et al. (2008) Infrared laser light further improves bone healing when associated with bone morphogenic proteins: An in vivo study in a rodent model. Photomed Laser Surg 26(1):55–60

    Article  PubMed  Google Scholar 

  18. Lee JY et al. (2015) Effect of low-level laser therapy on oral keratinocytes exposed to bisphosphonate. Lasers Med Sci 30(2):635–643

    Article  PubMed  Google Scholar 

  19. Genot-Klastersky MT et al. (2008) The use of low-energy laser (LEL) for the prevention of chemotherapy-and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies. Support Care Cancer 16:1381–1387

    Article  CAS  PubMed  Google Scholar 

  20. Peterson DE et al. (2011) ESMO Guidelines working group. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol 6:vi78–vi84

    Google Scholar 

  21. Lalla RV et al. (2014) Mucositis guidelines leadership group of the multinational association of supportive care in cancer and international society of oral oncology. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120(10):1453–1461

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mester E, Mester AF, Mester A (1985) The biomedical effects of laser application. Lasers Surg Med 5:31–39

    Article  CAS  PubMed  Google Scholar 

  23. Karu TI (1988) Molecular mechanism of the therapeutic effect of low-intensity laser radiation. Lasers Life Sci 2:53–74

    Google Scholar 

  24. Zhang Y, Song S, Fong CC, Tsang CH, Yang Z, Yang M (2003) cDNA microarray analysis of gene expression profiles in human fibroblast cells irradiated with red light. J Investig Dermatol 120:849–857

    Article  CAS  PubMed  Google Scholar 

  25. Garavello-Freitas I, Baranauskas V, Joazeiro PP, et al. (2003) Low-power laser irradiation improves histomorphometrical parameters and bone matrix organization during tibia wound healing in rats. J Photochem Photobiol B 70:81–89

    Article  CAS  PubMed  Google Scholar 

  26. Yu HS, Chang KL, Yu CL, Chen JW, Chen GS (1996) Low-energy helium-neon laser irradiation stimulates interleukin-1 alpha and interleukin-8 release from cultured human keratinocytes. J Investig Dermatol 107:593–596

    Article  CAS  PubMed  Google Scholar 

  27. Kipshidze N, Nikolaychik V, Keelan MH, Shankar LR, Khanna A, Kornowski R, Leon M, Moses J (2001) Low-power helium: neon laser irradiation enhances production of vascular endothelial growth factor and promotes growth of endothelial cells in vitro. Lasers Surg Med 28:355–364

    Article  CAS  PubMed  Google Scholar 

  28. Yu W, Naim JO, Lanzafame RJ (1994) The effect of laser irradiation on the release of bFGF from 3T3 fibroblasts. Photochem Photobiol 59:167–170

    Article  CAS  PubMed  Google Scholar 

  29. Maiya GA, Kumar P, Rao L (2005) “Effect of low intensity helium-neon (He–Ne) laser irradiation on diabetic wound healing dynamics”. Photomed Laser Surg 23(2):187–190

    Article  PubMed  Google Scholar 

  30. Pourreau-Schneider N, Ahmed A, Soudry M, Jacquemier J, Kopp F, Franquin JC, Martin PM (1990) Helium-neon laser treatment transforms fibroblasts into myofibroblasts. Am J Pathol 137:171–178

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Rajaratnam S, Bolton P, Dyson M (1994) Macrophage responsiveness to laser therapy with varying pulsing frequencies. Laser Ther 6:107–112

    Article  Google Scholar 

  32. Rochkind S, Leider-Trejo L, Nissan M, et al. (2007) Efficacy of 780-nm laser phototherapy on peripheral nerve regeneration after neurotube reconstruction procedure (double-blind randomized study). Photomed Laser Surg 25:137–143

    Article  PubMed  Google Scholar 

  33. Rochkind S, Drory V, Alon M, et al. (2007) Laser phototherapy (780 nm), a new modality in treatment of long-term incomplete peripheral nerve injury: a randomized double-blind placebo-controlled study. Photomed Laser Surg 25:436–442

    Article  PubMed  Google Scholar 

  34. Stein E, Koehn J, Sutter W, Wendtlandt G, Wanschitz F, Thurnher D, et al. (2008) Initial effects of low-level laser therapy on growth and differentiation of human osteoblast-like cells. Wien Klin Wochenschr 120(3–4):112–117

    Article  CAS  PubMed  Google Scholar 

  35. Yamamoto M, Tamura K, Hiratsuka K, Abiko Y (2001) Stimulation of MCM3 gene expression in osteoblast by low level laser irradiation. Lasers Med Sci 16(3):213–217

    Article  CAS  PubMed  Google Scholar 

  36. Hilal Bayrama, Halime Kenarb, Ferda Taşara, Vasıf Hasırcıb. Effect of low level laser therapy and zoledronate on the viability and ALP activity of Saos-2 cells; International Journal of Oral and Maxillofacial Surgery; 42/1; 01/2013, Pages 140–146

  37. Hagiwara S, Iwasaka H, Okuda K, Noguchi T (2007) GaAlAs (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Lasers Surg Med 39(10):797–802

    Article  PubMed  Google Scholar 

  38. Albertini R, Villaverde AB, Aimbire F, Salgado MA, Bjordal JM, Alves LP, Munin E, Costa MS (2007) Anti-inflammatory effects of low-level laser therapy (LLLT) with two different red wavelengths (660 nm and 684 nm) in carrageenan-induced rat paw edema. J Photochem Photobiol B 89(1):50–55

    Article  CAS  PubMed  Google Scholar 

  39. Gal D, Chokshi SK, Mosseri M, Clarke RH, Isner JM (1992) Percutaneous delivery of low-level laser energy reverses histamine-induced spasm in atherosclerotic Yucatan microswine. Circulation 85(2):756–768

    Article  CAS  PubMed  Google Scholar 

  40. Huang TH, Yu Chuan L, Kao CT (2012) Low-level diode laser therapy reduces lipopolysaccharide (LPS)-induced bone cell inflammation. Lasers Med Sci 27(Issue 3):621–627

    Article  PubMed  Google Scholar 

  41. Gutknecht N, Franzen R, Schippers M, Lampert F (2004) Bactericidal effect of a 980- nm diode laser in the root canal wall dentin of bovine teeth. J Clin Laser Med Surg 22(1):9–13

    Article  CAS  PubMed  Google Scholar 

  42. Nussbaum EL, Lilge L, Mazzulli T (2002) Effects of 810 nm laser irradiation on in vitro growth of bacteria: comparison of continuous wave and frequency modulated light. Lasers Surg Med 31(5):343–351

  43. Saad F, Brown JE, Van Barrios Poznak C et al. (2012) Incidence, risk factors and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active controlled phase III in cancer patients with bone metastases. Ann Oncol 23:1341–1347

  44. Stopeck AT1, Lipton A, Body JJ et al. (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 28(35):5132–5139

  45. Sperandio FF, Giudice FS, Corrêa L et al. (2013) Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway. J Biophotonics 6(10):839–847

Download references

Author information

Authors and Affiliations

  1. Institut Jules Bordet, Centre des Tumeurs de l’Université Libre de Bruxelles, Bruxelles, Belgique, 1, Rue Heger-Bordet, 1000, Brussels, Belgium

    S. Latifyan, M. T. Genot & J. Klastersky

Authors
  1. S. Latifyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. T. Genot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Klastersky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Klastersky.

Ethics declarations

Conflict of interest

The authors do not have any relevant conflict of interest in relation with the present review

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Latifyan, S., Genot, M.T. & Klastersky, J. Bisphosphonate-related osteonecrosis of the jaw: a review of the potential efficacy of low-level laser therapy. Support Care Cancer 24, 3687–3693 (2016). https://doi.org/10.1007/s00520-016-3139-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3139-9

Keywords

Search

Navigation